Skip to main content

Table 3 Predictors of the presence of at least one treatment limitation

From: Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections

Predictor

b

SE

OR

95% CI

p-value

Sex (female vs. male)

− 0.47

0.33

0.63

0.29

1.15

0.129

Age

0.13

0.02

1.14

1.11

1.20

0.001

PAD

0.32

0.79

1.37

0.28

7.54

0.664

Cardiovascular disease

− 0.73

0.37

0.48

0.23

0.95

0.033

Obstructive airway disease

0.32

0.47

1.38

0.58

3.42

0.482

Malignant disease

0.71

0.42

2.03

0.97

5.21

0.074

Dementia

2.06

1.16

7.87

3.35

33.5

0.001

CCI

0.17

0.09

1.19

1.02

1.45

0.036

eGFR ≤ 55 (ml/min)

0.95

0.32

2.57

1.43

5.00

0.002

SpO2 ≤ 93%

− 0.34

0.33

0.71

0.37

1.34

0.289

Neutrophils ≥ 5 (G/l)

0.11

0.33

1.11

0.58

2.08

0.723

CRP ≥ 7 (mg/dl)

− 0.04

0.33

0.96

0.49

1.82

0.894

  1. For cardiovascular disease and obstructive airway disease compare with Table 2. The results shown are based on 439 patients having complete data for all of the predictors included
  2. Bold p-values represent statistical significance (< 0.05)
  3. b Regression coefficient, SE standard error of regression coefficient, OR odds ratio corresponding to the regression coefficient, CI confidence interval of odds ratio, PAD peripheral artery disease, CCI Charlson comorbidity index, eGFR estimated glomerular filtration rate